Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries.
Kamusheva M, Manova M, Savova AT, Petrova GI, Mitov K, Harsányi A, Kaló Z, Márky K, Kawalec P, Angelovska B, Lakić D, Tesar T, Draganic P, Geitona M, Hatzikou M, Paveliu MS, Männik A. Kamusheva M, et al. Among authors: kawalec p. Front Pharmacol. 2018 Jul 20;9:795. doi: 10.3389/fphar.2018.00795. eCollection 2018. Front Pharmacol. 2018. PMID: 30079023 Free PMC article.
Pharmaceutical Regulation in Central and Eastern European Countries: A Current Review.
Kawalec P, Tesar T, Vostalova L, Draganic P, Manova M, Savova A, Petrova G, Rugaja Z, Männik A, Sowada C, Stawowczyk E, Harsanyi A, Inotai A, Turcu-Stiolica A, Gulbinovič J, Pilc A. Kawalec P, et al. Front Pharmacol. 2017 Dec 18;8:892. doi: 10.3389/fphar.2017.00892. eCollection 2017. Front Pharmacol. 2017. PMID: 29326583 Free PMC article.
The European challenges of funding orphan medicinal products.
Szegedi M, Zelei T, Arickx F, Bucsics A, Cohn-Zanchetta E, Fürst J, Kamusheva M, Kawalec P, Petrova G, Slaby J, Stawowczyk E, Vocelka M, Zechmeister-Koss I, Kaló Z, Molnár MJ. Szegedi M, et al. Among authors: kawalec p. Orphanet J Rare Dis. 2018 Nov 6;13(1):184. doi: 10.1186/s13023-018-0927-y. Orphanet J Rare Dis. 2018. PMID: 30396361 Free PMC article.
Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries.
Malinowski KP, Kawalec P, Trąbka W, Czech M, Petrova G, Manova M, Savova A, Draganić P, Vostalová L, Slabý J, Männik A, Márky K, Rugaja Z, Gulbinovic J, Tesar T, Paveliu MS. Malinowski KP, et al. Among authors: kawalec p. Front Pharmacol. 2019 May 8;10:487. doi: 10.3389/fphar.2019.00487. eCollection 2019. Front Pharmacol. 2019. PMID: 31139080 Free PMC article.
Reimbursement Status and Recommendations Related to Orphan Drugs in European Countries.
Stawowczyk E, Malinowski KP, Kawalec P, Bobiński R, Siwiec J, Panteli D, Eckhardt H, Simoens S, Agusti A, Dooms M, Pilc A. Stawowczyk E, et al. Among authors: kawalec p. Front Pharmacol. 2019 Nov 27;10:1279. doi: 10.3389/fphar.2019.01279. eCollection 2019. Front Pharmacol. 2019. PMID: 31827433 Free PMC article.
Potential Cost-Savings From the Use of the Biosimilars in Slovakia.
Tesar T, Golias P, Kobliskova Z, Wawruch M, Kawalec P, Inotai A. Tesar T, et al. Among authors: kawalec p. Front Public Health. 2020 Aug 21;8:431. doi: 10.3389/fpubh.2020.00431. eCollection 2020. Front Public Health. 2020. PMID: 32974261 Free PMC article.
Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe.
Malinowski KP, Kawalec P, Trąbka W, Sowada C, Petrova G, Manova M, Savova A, Draganić P, Slabý J, Männik A, Márky K, Rugaja Z, Gulbinovic J, Tesar T, Paveliu MS. Malinowski KP, et al. Among authors: kawalec p. Orphanet J Rare Dis. 2020 Oct 8;15(1):277. doi: 10.1186/s13023-020-01556-9. Orphanet J Rare Dis. 2020. PMID: 33032634 Free PMC article.
118 results